Danish pharma company restructures amid US and EU patent disputes

Gibson Dunn & Crutcher and Davis Polk & Wardwell have helped Danish drugs manufacturer Forward Pharma complete a corporate restructuring, which the company says should guard it against the outcome of a number of patent disputes in the US and Europe.

Get unlimited access to all Global Restructuring Review content